35788-31-9 Usage
Uses
Used in Pharmaceutical Research:
(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-[2-(dimethylamino)ethyl]-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) is used as a pharmaceutical research compound for its ability to interact with various enzymes and biological processes. Its unique structure allows it to be a potential candidate for the development of new drugs and therapies.
Used in Biochemistry and Molecular Biology Research:
In the fields of biochemistry and molecular biology, (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-[2-(dimethylamino)ethyl]-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) serves as an important research tool. Its interactions with enzymes and other biological molecules can provide valuable insights into the mechanisms of various cellular processes, contributing to a better understanding of biological systems and the development of targeted therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 35788-31-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,7,8 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 35788-31:
(7*3)+(6*5)+(5*7)+(4*8)+(3*8)+(2*3)+(1*1)=149
149 % 10 = 9
So 35788-31-9 is a valid CAS Registry Number.
35788-31-9Relevant academic research and scientific papers
Modification of the 5' Position of Purine Nucleosides. 2. Synthesis and Some Cardiovascular Properties of Adenosine-5'-(N-substituted)carboxamides
Prasad, Raj Nandan,Bariana, Dilbagh S.,Fung, Anthony,Savic, Milica,Tietje, Karin,et al.
, p. 313 - 319 (2007/10/02)
We have shown previously that the esters of adenosine-5'-carboxylic acid (10) represent a new class of potent nontoxic coronary vasodilators.For example, the ethyl ester (12), which is active by an intraduodenal or intravenous route in dogs, causes a larg
Adenosine-5'-carboxylic acid amides
-
, (2008/06/13)
Adenosine-5'-carboxylic acid amides represented by the formula STR1 wherein R1 and R2 are each selected from the group consisting of hydrogen, loweralkyl, lowerhaloalkyl, lowerhydroxyalkyl, lowercycloalkyl, loweralkylcycloalkyl, loweralkenyl, lowerhaloalkenyl, lowerhydroxyalkenyl, loweralkynyl, lowerhaloalkynyl, benzylamino, phenyl, loweralkylphenyl, loweralkoxyloweralkyl, substituted phenyl, 2-methylfuran or di(C1 -C4)alkylamino(C1 -C4)alkyl, adamantyl or R1 and R2 taken together form a 5 or 6 membered heterocyclic moiety; R3 and R4 are hydrogen or acyl, or taken together form an isopropylidene or a benzylidene group; or a pharmaceutically acceptable acid addition salt thereof.
